Eisai (Japan)
Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Eisai (Japan), Japan, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
46%
Total
Publications
4.6K
Total Open
Publications
2.1K
Total
Citations
153K
Open Access
Percentage
46%
Total
Publications
4.6K
Total Open
Publications
2.1K
Total
Citations
153K
Breakdown
Publisher Open
22%
Both
20%
Other Platform Open
4%
Closed
54%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 32%
621
Hybrid 28%
535
No Guarantees 40%
757
Other Platform Open
Domain 77%
834
Other Internet 19%
205
Institution 15%
167
Preprint 3%
30
Public 2%
22
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 835 |
DOI | Other Internet | 205 |
Europe PMC | Domain | 45 |
Royal Netherlands Academy of Arts and Sciences | Institution | 22 |
Figshare | Public | 20 |
bioRxiv | Preprint | 18 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 14 |
Yonsei University | Institution | 12 |
University of Melbourne | Institution | 8 |
Istituto di Ematologia di Bologna | Institution | 8 |